United States · FDA National Drug Code directory
ZYPREXA Relprevv
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61269-662_9c56e9db-742e-4263-96b4-d92064f9baba
- Product NDC
- 61269-662
- Form
- KIT
- Composition / generic term
- Olanzapine pamoate
- Labeler
- H2-Pharma LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20091211
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (61269-662-20) * 2.7 mL in 1 VIAL * 3 mL in 1 VIAL · 61269-662-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →